Literature DB >> 1381780

A proarrhythmic response to sodium channel blockade: modulation of the vulnerable period in guinea pig ventricular myocardium.

V V Nesterenko1, A A Lastra, L V Rosenshtraukh, C F Starmer.   

Abstract

The vulnerable period (VP) is an interval of time during the cardiac cycle within which premature stimulation may lead to trains of responses (one: many stimulus-response coupling). Although the VP parallels the recovery of sodium channel availability, modulators of its boundaries remain unclear. Numerical studies of a uniform cable demonstrated that reduction in sodium channel availability increased the range of premature stimuli, resulting in unidirectional block, a precursor of reentrant activation. Consequently, we hypothesized that the kinetics of use-dependent sodium channel blockade could reflect one dimension of a drug's proarrhythmic potential. In strips from guinea pig right ventricle, we probed the boundaries of the VP in the presence of use-dependent sodium channel antagonists utilizing a train of stimuli followed by a premature stimulus. Under drug-free conditions when the sites of drive and premature stimulation were the same, the VP was less than 4 ms in duration. When the drive and premature sites were different, the drug-free VP was greater than 5 ms in 22 of 24 preparations and 0 in the other two, with an average VP duration of 16 +/- 10 ms (mean +/- SD). In the presence of 1 microM moricizine, VP = 17 +/- 4 ms; 12 microM moricizine, VP = 35 +/- 4 ms; 3 microM flecainide, VP = 50 +/- 17 ms; and 4 microM quinidine, VP = 2 +/- 1 ms. These results suggest that residual unsuppressed premature ventricular contractions (PVCs) in the presence of some class 1 drugs have a greater potential for initiating a proarrhythmic response than PVCs in the absence of a class 1 drug.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381780

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  New aspects of vulnerability in heterogeneous models of ventricular wall and its modulation by loss of cardiac sodium channel function.

Authors:  A Kapela; N Tsoukias; A Bezerianos
Journal:  Med Biol Eng Comput       Date:  2005-05       Impact factor: 2.602

2.  Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction.

Authors:  H Todt; G Krumpl; N Zojer; K Krejcy; G Raberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

3.  Kinetics of rate-dependent slowing of intraventricular conduction by the class Ib antiarrhythmic agent tocainide in vivo.

Authors:  H Todt; N Zojer; G Raberger
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

4.  Vulnerability in an excitable medium: analytical and numerical studies of initiating unidirectional propagation.

Authors:  C F Starmer; V N Biktashev; D N Romashko; M R Stepanov; O N Makarova; V I Krinsky
Journal:  Biophys J       Date:  1993-11       Impact factor: 4.033

5.  Wavelet formation in excitable cardiac tissue: the role of wavefront-obstacle interactions in initiating high-frequency fibrillatory-like arrhythmias.

Authors:  J M Starobin; Y I Zilberter; E M Rusnak; C F Starmer
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

6.  KChIP2 is a core transcriptional regulator of cardiac excitability.

Authors:  Drew M Nassal; Xiaoping Wan; Haiyan Liu; Danielle Maleski; Angelina Ramirez-Navarro; Christine S Moravec; Eckhard Ficker; Kenneth R Laurita; Isabelle Deschênes
Journal:  Elife       Date:  2017-03-06       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.